NO20065077L - Farmasoytisk sammensetning omfattende et salt av mirtazapin. - Google Patents

Farmasoytisk sammensetning omfattende et salt av mirtazapin.

Info

Publication number
NO20065077L
NO20065077L NO20065077A NO20065077A NO20065077L NO 20065077 L NO20065077 L NO 20065077L NO 20065077 A NO20065077 A NO 20065077A NO 20065077 A NO20065077 A NO 20065077A NO 20065077 L NO20065077 L NO 20065077L
Authority
NO
Norway
Prior art keywords
salt
mirtazapine
pharmaceutical composition
acid
rmirtazapine
Prior art date
Application number
NO20065077A
Other languages
English (en)
Inventor
Gerardus Johannes Kemperman
Sytske Hyke Moolenar
Kees Van Der Voort Maarschalk
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20065077L publication Critical patent/NO20065077L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer et farmasøytisk egnet ikke-sublimerende og fast salt av en enantiomer av mirtazapin, spesielt et mirtazapinsalt valgt fra listen av saltet av maleinsyre, bromhydrogensyre og fumarsyre, for anvendelse ved fremstilling av et farmasøytisk preparat omfattende et salt av S-eller Rmirtazapin.
NO20065077A 2004-04-21 2006-11-03 Farmasoytisk sammensetning omfattende et salt av mirtazapin. NO20065077L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21
PCT/EP2005/051714 WO2005102352A1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Publications (1)

Publication Number Publication Date
NO20065077L true NO20065077L (no) 2006-11-14

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065077A NO20065077L (no) 2004-04-21 2006-11-03 Farmasoytisk sammensetning omfattende et salt av mirtazapin.

Country Status (31)

Country Link
US (1) US20070111993A1 (no)
EP (1) EP1729777B1 (no)
JP (2) JP5260959B2 (no)
CN (2) CN1942191B (no)
AR (1) AR049028A1 (no)
AT (1) ATE424210T1 (no)
AU (1) AU2005235383B2 (no)
BR (1) BRPI0509953A (no)
CA (1) CA2561281C (no)
CY (1) CY1109018T1 (no)
DE (1) DE602005013066D1 (no)
DK (1) DK1729777T3 (no)
EC (1) ECSP066938A (no)
ES (1) ES2321961T3 (no)
HR (1) HRP20090190T1 (no)
IL (1) IL178201A (no)
LV (1) LV13556B (no)
MX (1) MXPA06011830A (no)
MY (1) MY144899A (no)
NO (1) NO20065077L (no)
NZ (1) NZ550052A (no)
PE (1) PE20060400A1 (no)
PL (1) PL1729777T3 (no)
PT (1) PT1729777E (no)
RS (1) RS50764B (no)
RU (1) RU2375362C2 (no)
SI (1) SI1729777T1 (no)
TW (1) TW200538100A (no)
UA (1) UA89773C2 (no)
WO (1) WO2005102352A1 (no)
ZA (1) ZA200608305B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
PT1067934E (pt) * 1998-04-02 2004-03-31 Akzo Nobel Nv Solucao anti-depressiva liquida oral
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
KR20020086945A (ko) * 2000-04-05 2002-11-20 악조 노벨 엔.브이. 비스테로이드성 항염증제를 포함하는 두통 치료용 약제조합물

Also Published As

Publication number Publication date
EP1729777A1 (en) 2006-12-13
CA2561281A1 (en) 2005-11-03
MXPA06011830A (es) 2007-03-23
JP2013136626A (ja) 2013-07-11
CN1942191B (zh) 2011-02-02
ZA200608305B (en) 2008-08-27
MY144899A (en) 2011-11-30
UA89773C2 (ru) 2010-03-10
CY1109018T1 (el) 2014-07-02
CA2561281C (en) 2013-04-02
HRP20090190T1 (en) 2009-05-31
IL178201A (en) 2010-06-30
CN101824035A (zh) 2010-09-08
SI1729777T1 (sl) 2009-08-31
PL1729777T3 (pl) 2009-07-31
JP2007533705A (ja) 2007-11-22
AU2005235383B2 (en) 2010-05-27
AR049028A1 (es) 2006-06-21
ECSP066938A (es) 2006-12-20
US20070111993A1 (en) 2007-05-17
CN1942191A (zh) 2007-04-04
DE602005013066D1 (de) 2009-04-16
PT1729777E (pt) 2009-04-27
LV13556B (en) 2007-07-20
BRPI0509953A (pt) 2007-09-25
RU2006140988A (ru) 2008-05-27
AU2005235383A1 (en) 2005-11-03
JP5260959B2 (ja) 2013-08-14
RS50764B (sr) 2010-08-31
DK1729777T3 (da) 2009-06-08
RU2375362C2 (ru) 2009-12-10
NZ550052A (en) 2010-02-26
ATE424210T1 (de) 2009-03-15
ES2321961T3 (es) 2009-06-15
PE20060400A1 (es) 2006-05-27
TW200538100A (en) 2005-12-01
WO2005102352A1 (en) 2005-11-03
EP1729777B1 (en) 2009-03-04
IL178201A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
WO2009076141A8 (en) Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
AP2327A (en) Quinoline derivatives for the treatment of latent tuberculosis.
WO2006004636A3 (en) Fused heterocyclic kinase inhibitors
WO2007050802A3 (en) Novel opioid antagonists
EP1725535A4 (en) HIV integrase
IL177189A0 (en) Hiv integrase inhibitors
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
NO20064555L (no) HIV-integraseinhibitorer.
GEP20094784B (en) Sustained release pharmaceutical formulations
WO2008049116A3 (en) Substituted indoles
NO20092611L (no) Krystallinsk faststoff Rasagilin base
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK1939204T6 (da) Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf
WO2007034312A3 (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
NO332405B1 (no) Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen.
EP1756114A4 (en) HIV integrase
NO20065077L (no) Farmasoytisk sammensetning omfattende et salt av mirtazapin.
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
WO2007056625A3 (en) Thienopyridine b-raf kinase inhibitors
WO2008062282A3 (en) An improved process for the synthesis of solifenacin
DE602005003453D1 (de) Neue effektor-konjugate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
EP1874116A4 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIOUSITY
AP2006003759A0 (en) (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application